Karen Sterling
Stock Analyst at Westpark Capital
(2.81)
# 2,772
Out of 5,085 analysts
7
Total ratings
60%
Success rate
22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Karen Sterling
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TTRX Turn Therapeutics | Upgraded: Hold | $10 | $11.12 | -10.07% | 3 | Oct 23, 2026 | |
| CTSO Cytosorbents | Initiated Coverage: Buy | $9.5 | $5.24 | +81.30% | 1 | Oct 21, 2026 | |
| REGN Regeneron Pharmaceuticals | Initiated Coverage: Hold | n/a | $813.27 | n/a | 1 | Sep 15, 2023 | |
| NRXS NeurAxis | Initiated Coverage: Buy | $7.5 | $7.57 | n/a | 1 | Aug 23, 2023 | |
| VRTX Vertex Pharmaceuticals | Initiated Coverage: Hold | n/a | $529.69 | n/a | 1 | May 25, 2023 |
Turn Therapeutics
Oct 23, 2026
Upgraded: Hold
Price Target: $10
Current: $11.12
Upside: -10.07%
Cytosorbents
Oct 21, 2026
Initiated Coverage: Buy
Price Target: $9.5
Current: $5.24
Upside: +81.30%
Regeneron Pharmaceuticals
Sep 15, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $813.27
Upside: n/a
NeurAxis
Aug 23, 2023
Initiated Coverage: Buy
Price Target: $7.5
Current: $7.57
Upside: n/a
Vertex Pharmaceuticals
May 25, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $529.69
Upside: n/a